SCiAN is a specialized biometrics partner helping sponsors navigate complex clinical development.
Proven expertise across Clinical Data Management, Biostatistics, and Statistical Programming, delivering high-quality solutions that support informed decision-making throughout the clinical development process.
Scalable support tailored to the needs of both emerging biotechnology companies and global pharmaceutical organizations, ensuring the right level of expertise at every stage of development.
Deep regulatory experience supporting global submissions, with a focus on quality, compliance, and adherence to evolving industry standards and expectations.
A strong track record of supporting clinical programs through acquisitions, licensing agreements, and strategic partnerships while maintaining continuity and operational efficiency.
Seamless retention of program knowledge across study phases and organizational change, helping sponsors reduce risk, maintain momentum, and achieve development milestones with confidence.
Celebrating 40 Years in Clinical Trials
Over the past forty years, SCiAN has been shaped by the rigor and discipline of our earliest collaborations with major pharmaceutical clients. Those formative years taught us what excellence in clinical development truly requires. As the biotech sector emerged and accelerated through the 1990s, we grew alongside it—adapting, learning, and building a model designed for scientific agility and operational precision.
Today, we are proud to support a new generation of innovators advancing targeted cell and gene therapies, often in rare and ultra‑rare diseases where every data point matters. These partnerships reflect the same principles that guided us from the beginning: scientific clarity, methodological integrity, and a commitment to helping promising therapies reach patients who urgently need them.
As we celebrate 40 years in business, I want to express my sincere appreciation to our current and past clients, whose trust has shaped our journey; to the many bright scientific minds we’ve had the privilege to collaborate with; and to our exceptional colleagues—past and present—whose dedication built the foundation we stand on today.
Miklos L. Schulz, Ph.D.
President & CEO
SCiAN collaborates with global Clinical Operations CROs that require specialized biometrics expertise for complex cell and gene therapy programs. Our experience in rare‑disease development, accelerated IND‑stage programs, and high‑precision data operations enables ClinOps organizations to expand their capabilities with a trusted biometrics partner.
We support multiple collaboration models—including integrated FSP, co‑sourced biometrics, and white‑label delivery—designed to ensure continuity across studies and functions. These alliances strengthen operational execution, enhance data quality, and help sponsors move efficiently from concept to submission.